DMK

David M. Knott Portfolio holdings

AUM $264M
1-Year Return 57.14%
This Quarter Return
+2.62%
1 Year Return
+57.14%
3 Year Return
+78.48%
5 Year Return
+218.77%
10 Year Return
–
AUM
$264M
AUM Growth
-$12.3M
Cap. Flow
-$14.4M
Cap. Flow %
-5.45%
Top 10 Hldgs %
46.32%
Holding
167
New
20
Increased
21
Reduced
21
Closed
17

Top Buys

1
MITA
Coliseum Acquisition Corp. Class A Ordinary Share
MITA
$9.56M
2
GREE icon
Greenidge Generation Holdings
GREE
$5.72M
3
MITAW
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M
4
BRIV
B. Riley Principal 250 Merger Corp. Class A common stock
BRIV
$3.4M
5
CLMT icon
Calumet Specialty Products
CLMT
$3.28M

Top Sells

1
MITAU
Coliseum Acquisition Corp. Unit
MITAU
$14.7M
2
PSTH
Pershing Square Tontine Holdings, Ltd.
PSTH
$6.26M
3
FSK icon
FS KKR Capital
FSK
$4.31M
4
FAZE
FaZe Holdings Inc. Common Stock
FAZE
$3.41M
5
CNST
Constellation Pharmaceuticals, Inc.
CNST
$3.11M

Sector Composition

1 Financials 31.03%
2 Healthcare 24.22%
3 Materials 12.73%
4 Communication Services 7.32%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AVDL
26
Avadel Pharmaceuticals
AVDL
$1.46B
$2.96M 1.07%
301,864
-3,058
-1% -$30K
GLHAW
27
DELISTED
Glass Houses Acquisition Corp. Warrant
GLHAW
$2.88M 1.04%
250,000
– –
UTHR icon
28
United Therapeutics
UTHR
$17.2B
$2.82M 1.03%
15,300
– –
JPM icon
29
JPMorgan Chase
JPM
$835B
$2.74M 1%
16,740
-1,430
-8% -$234K
BMY icon
30
Bristol-Myers Squibb
BMY
$95.3B
$2.51M 0.91%
42,409
-1,000
-2% -$59.2K
AB icon
31
AllianceBernstein
AB
$4.34B
$2.5M 0.91%
50,500
– –
HZNP
32
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$2.19M 0.8%
20,000
-12,000
-38% -$1.31M
HZAC
33
DELISTED
Horizon Acquisition Corporation
HZAC
$2.1M 0.76%
+210,100
New +$2.1M
EIGR
34
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$2.09M 0.76%
10,416
+864
+9% +$173K
TWLVW
35
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.98M 0.72%
171,666
– –
PMGM
36
DELISTED
Priveterra Acquisition Corp. II Class A Common Stock
PMGM
$1.97M 0.72%
200,000
– –
MSAC
37
DELISTED
Medicus Sciences Acquisition Corp. Class A Ordinary Share
MSAC
$1.95M 0.71%
+200,000
New +$1.95M
INVA icon
38
Innoviva
INVA
$1.33B
$1.93M 0.7%
115,269
+67,471
+141% +$1.13M
ZGNX
39
DELISTED
Zogenix, Inc.
ZGNX
$1.89M 0.69%
124,688
– –
INCY icon
40
Incyte
INCY
$16.7B
$1.82M 0.66%
+26,475
New +$1.82M
FAZE
41
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
$1.73M 0.63%
176,963
-350,000
-66% -$3.41M
KAIRW
42
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.69M 0.61%
146,528
– –
TGTX icon
43
TG Therapeutics
TGTX
$4.95B
$1.65M 0.6%
49,592
-781
-2% -$26K
CHRS icon
44
Coherus Oncology, Inc. Common Stock
CHRS
$153M
$1.65M 0.6%
102,555
+2,900
+3% +$46.6K
QURE icon
45
uniQure
QURE
$961M
$1.5M 0.54%
46,766
– –
XENE icon
46
Xenon Pharmaceuticals
XENE
$2.98B
$1.44M 0.52%
94,488
-46,063
-33% -$704K
AUPH icon
47
Aurinia Pharmaceuticals
AUPH
$1.66B
$1.39M 0.51%
62,896
-101,944
-62% -$2.26M
BRIVW
48
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.49%
+116,666
New +$1.34M
VKTX icon
49
Viking Therapeutics
VKTX
$2.97B
$1.31M 0.47%
208,102
– –
PMGMW
50
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.42%
100,000
– –
1
2
3 4 5